Get started
CARA THERAPEUTICS INC COM USD0.001CARA THERAPEUTICS INC COM USD0.001CARA THERAPEUTICS INC COM USD0.001

CARA THERAPEUTICS INC COM USD0.001

No trades
Buy 0HTC
Overview
Financials News Ideas Discussions Technicals Seasonals

0HTC chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.85 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.0386USD
Net income (FY)
‪−118.51 M‬USD
Revenue (FY)
‪20.97 M‬USD
Shares float
‪45.76 M‬
Beta (1Y)
1.77

Employees


Employees (FY)
55
Change (1Y)
−51 −48.11%
Revenue / Employee (1Y)
‪381.24 K‬USD
Net income / Employee (1Y)
‪−2.15 M‬USD

About Cara Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher A. Posner
Website
caratherapeutics.com
Headquarters
Stamford
Founded
2004
FIGI
BBG00JVRNB86
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0HTC is 0.3104 USD — it has increased by 6.96% in the past 24 hours. Watch CARA THERAPEUTICS INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CARA THERAPEUTICS INC COM USD0.001 stocks are traded under the ticker 0HTC.
0HTC stock has risen by 16.74% compared to the previous week, the month change is a −0.89% fall, over the last year CARA THERAPEUTICS INC COM USD0.001 has showed a −76.13% decrease.
0HTC reached its all-time high on Apr 9, 2021 with the price of 29.1720 USD, and its all-time low was 0.2406 USD and was reached on Jun 20, 2024. View more price dynamics on 0HTC chart.
See other stocks reaching their highest and lowest prices.
0HTC stock is 12.56% volatile and has beta coefficient of 1.77. Track CARA THERAPEUTICS INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is CARA THERAPEUTICS INC COM USD0.001 there?
Today CARA THERAPEUTICS INC COM USD0.001 has the market capitalization of ‪15.85 M‬, it has increased by 13.65% over the last week.
Yes, you can track CARA THERAPEUTICS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
CARA THERAPEUTICS INC COM USD0.001 is going to release the next earnings report on Nov 4, 2024. Keep track of upcoming events with our Earnings Calendar.
0HTC earnings for the last quarter are −0.27 USD per share, whereas the estimation was −0.27 USD resulting in a 1.46% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about CARA THERAPEUTICS INC COM USD0.001 earnings.
CARA THERAPEUTICS INC COM USD0.001 revenue for the last quarter amounts to ‪1.10 M‬ USD, despite the estimated figure of ‪1.18 M‬ USD. In the next quarter, revenue is expected to reach ‪2.02 M‬ USD.
0HTC net income for the last quarter is ‪−20.02 M‬ USD, while the quarter before that showed ‪−30.70 M‬ USD of net income which accounts for 34.79% change. Track more CARA THERAPEUTICS INC COM USD0.001 financial stats to get the full picture.
No, 0HTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 1, 2024, the company has 55.00 employees. See our rating of the largest employees — is CARA THERAPEUTICS INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARA THERAPEUTICS INC COM USD0.001 EBITDA is ‪−104.26 M‬ USD, and current EBITDA margin is −578.20%. See more stats in CARA THERAPEUTICS INC COM USD0.001 financial statements.
Like other stocks, 0HTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARA THERAPEUTICS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARA THERAPEUTICS INC COM USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARA THERAPEUTICS INC COM USD0.001 stock shows the sell signal. See more of CARA THERAPEUTICS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.